Literature DB >> 20586922

Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.

L A Valentino1.   

Abstract

Arthropathy is a frequent and serious complication of repeated joint bleeding in patients with hemophilia, resulting in pain, deformity, and disability. Although the pathogenesis of hemophilic arthropathy has not been fully elucidated, it appears to have similarities with the degenerative joint damage that occurs in osteoarthritis and the inflammatory processes associated with rheumatoid arthritis. This article reviews the potential actions of various blood constituents on joint components that culminate in the development of hemophilic arthropathy.
© 2010 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2010        PMID: 20586922     DOI: 10.1111/j.1538-7836.2010.03962.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  69 in total

1.  [Prophylactic treatment with low- and intermediate-dose factor VIII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis].

Authors:  Jin-Mu Zhuang; Xue-Yan Sun; Xuan Zhou; Zhu-Qin Liu; Jing Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Osteochondral repair in hemophilic ankle arthropathy: from current options to future perspectives.

Authors:  Roberto Buda; Marco Cavallo; Francesco Castagnini; Enrico Ferranti; Simone Natali; Sandro Giannini
Journal:  Joints       Date:  2016-01-31

3.  Tailoring care to haemophilia patients' needs: which specialty and when?

Authors:  Massimo Morfini; Gary Benson; Victor Jiménez-Yuste; Rolf Ljung; Pier Mannuccio Mannucci; Gianluigi Pasta; Eduardo Remor; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2015-05-20       Impact factor: 3.443

4.  A microfluidic model of hemostasis sensitive to platelet function and coagulation.

Authors:  R M Schoeman; K Rana; N Danes; M Lehmann; J A Di Paola; A L Fogelson; K Leiderman; K B Neeves
Journal:  Cell Mol Bioeng       Date:  2016-10-24       Impact factor: 2.321

5.  Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project.

Authors:  Marilyn J Manco-Johnson; J Michael Soucie; Joan Cox Gill
Journal:  Blood       Date:  2017-02-09       Impact factor: 22.113

6.  Inflammatory focal bone destruction in femoral heads with end-stage haemophilic arthropathy: a study on clinic samples with micro-CT and histological analyses.

Authors:  S Zhang; C Lu; J Ying; P Wang; T Xu; D Chen; H Jin; P Tong
Journal:  Haemophilia       Date:  2015-09-20       Impact factor: 4.287

7.  Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.

Authors:  Shannon M Zintner; Juliana C Small; Giulia Pavani; Lynn Dankner; Oscar A Marcos-Contreras; Phyllis A Gimotty; Mads Kjelgaard-Hansen; Bo Wiinberg; Paris Margaritis
Journal:  Blood Adv       Date:  2019-02-12

8.  Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.

Authors:  Yohann Repessé; Ivan Peyron; Jordan D Dimitrov; Suryasarathi Dasgupta; Elika Farrokhi Moshai; Catherine Costa; Annie Borel-Derlon; Benoit Guillet; Roseline D'Oiron; Achille Aouba; Chantal Rothschild; Johannes Oldenburg; Anna Pavlova; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

9.  Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.

Authors:  Harini Raghu; Alice Jone; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Jay L Degen; Matthew J Flick
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  Vascular remodeling underlies rebleeding in hemophilic arthropathy.

Authors:  Vikas Bhat; Merissa Olmer; Shweta Joshi; Donald L Durden; Thomas J Cramer; Richard Fw Barnes; Scott T Ball; Tudor H Hughes; Mauricio Silva; James V Luck; Randy E Moore; Laurent O Mosnier; Annette von Drygalski
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.